Sulfasalazine USP
Composition : Sulfasalazine USP 500mg Enteric Coated Tablet.
Indication : Rheumatoid arthritis & Juvenile arthritis : Sulfasalazine is indicated for Rheumatic arthritis and Juvenile arthritis which has failed to responded to nonsteroidal anti-inflammatory drugs (NSAIDs).
Ulcerative colitis and Crohn's disease :
Sulfasalazine is also indicated for the
treatment and management of severe and
acute attacks of Ulcerative colitis, and in the
treatment of Crohn's disease, especially in
patients with colonic involvement.
Dosage and administration : The dosage of Sulfasalazine (Sulfacol) tablets should be individually adjusted according to the patient's tolerance and response to the treatment and taken in evenly divided doses preferably after meals. Please see prescribing description for more information.
Pregnancy and lactation : Pregnancy catergory B. Sulfasalazine
should be administered during pregnancy
only if the potential benefits outweigh the
potential risk to the fetus. Caution should be
exercised when sulfasalazine is administered
to a nursing mother.
Packing : 3x10's tablets in blister pack.